GlassScriptPhysician profile
Reginald Inman Low
NPI 1821070780
$37,250.21
in general payments reported to CMS, 2019-2025
16 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,344 · 2020: $13.08 · 2021: $61.42 · 2022: $86.44 · 2023: $21K · 2024: $7,304 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $26K · Food and Beverage: $1,796 · Consulting Fee: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $26,400.00 |
| Food and Beverage | $1,795.63 |
| Consulting Fee | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $27,586.31 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $8,156.86 | 2019-2024 | Synergy, Avvigo Guidance System |
| Recor Medical INC | $285.10 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Biotronik INC. | $266.09 | 2019-2023 | Pk Papyrus, Pantera Leo, Recross |
| Heartflow, INC. | $218.32 | 2023-2024 | Ffrct |
| Medtronic, INC. | $198.52 | 2023-2025 | Corevalve Evolut R |
| Abiomed | $127.54 | 2023 | Impella |
| Abbott Laboratories | $105.98 | 2023 | Coroflow |
| Alnylam Pharmaceuticals INC. | $101.94 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $90.71 | 2019 | |
| Philips North America LLC | $42.62 | 2023 | |
| Sanofi-Aventis U.S. LLC | $22.14 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.17 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.97 | 2019 | |
| Terumo Medical Corporation | $14.94 | 2025 | Progreat, Metacross Otw |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Low listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.